These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 21510943)

  • 1. The C-terminus of MIP-T3 protein is required for ubiquitin-proteasome-mediated degradation in human cells.
    Guo CW; Liu G; Xiong S; Ge F; Fuse T; Wang YF; Kitazato K
    FEBS Lett; 2011 May; 585(9):1350-6. PubMed ID: 21510943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-dependent proteolysis of the microtubule end-binding protein 1, EB1, is controlled by the COP9 signalosome: possible consequences for microtubule filament stability.
    Peth A; Boettcher JP; Dubiel W
    J Mol Biol; 2007 Apr; 368(2):550-63. PubMed ID: 17350042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells.
    Chen C; Sun X; Ran Q; Wilkinson KD; Murphy TJ; Simons JW; Dong JT
    Oncogene; 2005 May; 24(20):3319-27. PubMed ID: 15735697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis reveals novel binding partners of MIP-T3 in human cells.
    Guo CW; Xiong S; Liu G; Wang YF; He QY; Zhang XE; Zhang ZP; Ge F; Kitazato K
    Proteomics; 2010 Jun; 10(12):2337-47. PubMed ID: 20391533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent reporters for the ubiquitin-proteasome system.
    Salomons FA; Verhoef LG; Dantuma NP
    Essays Biochem; 2005; 41():113-28. PubMed ID: 16250901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
    Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
    Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
    Vandenberghe I; Créancier L; Vispé S; Annereau JP; Barret JM; Pouny I; Samson A; Aussagues Y; Massiot G; Ausseil F; Bailly C; Kruczynski A
    Biochem Pharmacol; 2008 Aug; 76(4):453-62. PubMed ID: 18577376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors.
    Kinyamu HK; Chen J; Archer TK
    J Mol Endocrinol; 2005 Apr; 34(2):281-97. PubMed ID: 15821097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
    von Mikecz A; Chen M; Rockel T; Scharf A
    Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAT10, a ubiquitin-independent signal for proteasomal degradation.
    Hipp MS; Kalveram B; Raasi S; Groettrup M; Schmidtke G
    Mol Cell Biol; 2005 May; 25(9):3483-91. PubMed ID: 15831455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-proteasome pathway mediates degradation of APH-1.
    He G; Qing H; Cai F; Kwok C; Xu H; Yu G; Bernstein A; Song W
    J Neurochem; 2006 Dec; 99(5):1403-12. PubMed ID: 17059559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Cidea protein stability by the ubiquitin-mediated proteasomal degradation pathway.
    Chan SC; Lin SC; Li P
    Biochem J; 2007 Dec; 408(2):259-66. PubMed ID: 17711404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caenorhabditis elegans DYF-11, an orthologue of mammalian Traf3ip1/MIP-T3, is required for sensory cilia formation.
    Kunitomo H; Iino Y
    Genes Cells; 2008 Jan; 13(1):13-25. PubMed ID: 18173744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and functional expression of a degradation-resistant novel isoform of p27Kip1.
    Hirano K; Hirano M; Zeng Y; Nishimura J; Hara K; Muta K; Nawata H; Kanaide H
    Biochem J; 2001 Jan; 353(Pt 1):51-57. PubMed ID: 11115398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid peptide attenuates the proteasome activity in neuronal cells.
    Oh S; Hong HS; Hwang E; Sim HJ; Lee W; Shin SJ; Mook-Jung I
    Mech Ageing Dev; 2005 Dec; 126(12):1292-9. PubMed ID: 16153690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of multiple ubiquitin signals in proteasome regulation.
    Isasa M; Zuin A; Crosas B
    Methods Mol Biol; 2012; 910():337-70. PubMed ID: 22821603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The size of the proteasomal substrate determines whether its degradation will be mediated by mono- or polyubiquitylation.
    Shabek N; Herman-Bachinsky Y; Buchsbaum S; Lewinson O; Haj-Yahya M; Hejjaoui M; Lashuel HA; Sommer T; Brik A; Ciechanover A
    Mol Cell; 2012 Oct; 48(1):87-97. PubMed ID: 22902562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic 2 receptors modulate cardiac proteasome function in a protein kinase G-dependent manner.
    Ranek MJ; Kost CK; Hu C; Martin DS; Wang X
    J Mol Cell Cardiol; 2014 Apr; 69():43-51. PubMed ID: 24508699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rad23 as a reciprocal agent for stimulating or repressing immune responses.
    Andersson HA; Passeri MF; Barry MA
    Hum Gene Ther; 2005 May; 16(5):634-41. PubMed ID: 15916488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolysis of γ-tubulin small complex proteins is mediated by the ubiquitin-proteasome system.
    Yin C; Lui ESW; Jiang T; Qi RZ
    FEBS Lett; 2021 Aug; 595(15):1987-1996. PubMed ID: 34107052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.